Developing COVID-19 therapeutics: An investment that needs to happen


Read next

Announcing the therapeutics accelerator

Announcing the COVID-19 Therapeutics Accelerator

We are joining forces with Wellcome and Mastercard to beef up our COVID-19 response—backed by $125 million in both new funding and money already earmarked to tackle this epidemic. The expertise of pharmaceutical companies will be critical to this endeavor, named the COVID-19 Therapeutics Accelerator
Mark Suzman CEO, Board Member, Bill & Melinda Gates Foundation
Green gloves and test tube

Identifying therapeutics: The role of COVID-19 Therapeutics Accelerator

Monalisa Chatterji, a senior program officer for the Bill & Melinda Gates Foundation's Discovery & Translational Sciences team, works on the discovery of novel candidate therapeutics.
Monalisa Chatterji Senior Program Officer, Bill & Melinda Gates Foundation